2018. Improvement of risk assessment in cutaneous melanoma (CM) by a prognostic 31-gene expression profile (31-GEP) test over AJCC-based staging alone. SKIN The Journal of Cutaneous Medicine. 2, (Dec. 2018), S70. DOI:https://doi.org/10.25251/skin.2.supp.70.